Cagrilintide
A long-acting amylin analogue studied for appetite and weight, often alongside semaglutide.
What it is
Cagrilintide is a modified version of amylin, a hormone released with insulin after meals.
How it works
Amylin signals fullness and slows stomach emptying. Cagrilintide is built to last about a week in the body.
What it is researched for
- Appetite and food intake
- Body weight in combination with semaglutide
Research status
Investigational. Not approved on its own; studied in trials as part of a combination.
What to watch for
- Nausea and other stomach effects
- Unknown long-term effects
Storage
Lyophilised powder keeps in the freezer or fridge, away from light. Once mixed with bacteriostatic water, keep it refrigerated and use it within about four weeks.
Common questions
Is Cagrilintide approved for human use?
Investigational. Not approved on its own; studied in trials as part of a combination.
Where can I read the research on Cagrilintide?
Use the PubMed, Europe PMC and clinical trials buttons on this page. They run a live search for Cagrilintide, so you see what is published today.
Educational reference only, not medical advice.